NasdaqGM - Nasdaq Real Time Price USD

Cerus Corporation (CERS)

1.6650 -0.0150 (-0.89%)
As of 1:51 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
156,367.0000
156,367.0000
162,048.0000
130,859.0000
91,920.0000
Cost of Revenue
69,967.0000
69,967.0000
74,954.0000
63,475.0000
41,157.0000
Gross Profit
86,400.0000
86,400.0000
87,094.0000
67,384.0000
50,763.0000
Operating Expense
112,725.0000
112,725.0000
121,175.0000
116,320.0000
109,096.0000
Operating Income
-26,325.0000
-26,325.0000
-34,081.0000
-48,936.0000
-58,333.0000
Net Non Operating Interest Income Expense
-8,386.0000
-8,386.0000
-5,831.0000
-4,923.0000
-3,746.0000
Other Income Expense
-2,611.0000
-2,611.0000
-2,425.0000
-198.0000
2,506.0000
Pretax Income
-37,322.0000
-37,322.0000
-42,337.0000
-54,057.0000
-59,573.0000
Tax Provision
325.0000
325.0000
488.0000
319.0000
284.0000
Net Income Common Stockholders
-37,489.0000
-37,489.0000
-42,779.0000
-54,374.0000
-59,857.0000
Diluted NI Available to Com Stockholders
-37,489.0000
-37,489.0000
-42,779.0000
-54,374.0000
-59,857.0000
Basic EPS
-0.21
--
-0.24
-0.32
-0.24
Diluted EPS
-0.21
--
-0.24
-0.32
-0.24
Basic Average Shares
180,270.0000
--
176,545.0000
171,279.0000
163,949.0000
Diluted Average Shares
180,270.0000
--
176,545.0000
171,279.0000
163,949.0000
Total Operating Income as Reported
-30,053.0000
-30,053.0000
-34,081.0000
-48,936.0000
-58,333.0000
Total Expenses
182,692.0000
182,692.0000
196,129.0000
179,795.0000
150,253.0000
Net Income from Continuing & Discontinued Operation
-37,489.0000
-37,489.0000
-42,779.0000
-54,374.0000
-59,857.0000
Normalized Income
-34,031.9600
-34,031.9600
-42,233.9000
-53,956.4400
-60,435.8900
Interest Expense
8,386.0000
8,386.0000
5,831.0000
4,923.0000
3,746.0000
Net Interest Income
-8,386.0000
-8,386.0000
-5,831.0000
-4,923.0000
-3,746.0000
EBIT
-28,936.0000
-28,936.0000
-36,506.0000
-49,134.0000
-55,827.0000
EBITDA
-26,337.0000
-26,337.0000
-33,522.0000
-45,986.0000
-52,718.0000
Reconciled Cost of Revenue
69,967.0000
69,967.0000
74,954.0000
63,475.0000
41,157.0000
Reconciled Depreciation
2,599.0000
2,599.0000
2,984.0000
3,148.0000
3,109.0000
Net Income from Continuing Operation Net Minority Interest
-37,489.0000
-37,489.0000
-42,779.0000
-54,374.0000
-59,857.0000
Total Unusual Items Excluding Goodwill
-4,376.0000
-4,376.0000
-690.0000
-572.0000
793.0000
Total Unusual Items
-4,376.0000
-4,376.0000
-690.0000
-572.0000
793.0000
Normalized EBITDA
-21,961.0000
-21,961.0000
-32,832.0000
-45,414.0000
-53,511.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-918.9600
-918.9600
-144.9000
-154.4400
214.1100
12/31/2020 - 1/31/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RCEL AVITA Medical, Inc.
8.75
-2.56%
 
DCTH Delcath Systems, Inc.
5.46
-2.51%
 
ICAD iCAD, Inc.
1.5799
+1.31%
 
FNA Paragon 28, Inc.
9.68
-3.68%
 
AXNX Axonics, Inc.
66.70
+0.35%
 
OM Outset Medical, Inc.
2.5340
+3.01%
 
AXGN AxoGen, Inc.
6.85
-1.72%
 
PACB Pacific Biosciences of California, Inc.
1.3750
-6.46%
 
AORT Artivion, Inc.
21.14
+1.73%
 
QTRX Quanterix Corporation
16.04
-0.37%